RYAN MILLER: Open Payments
NPI 1952670960 · JAMESTOWN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,570 in 151 payments from 26 companies in 2025. Trend: 2023 $1,849 · 2024 $2,791 · 2025 $2,570
Food & beverage: $2,570
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 73 | $937 |
| Forte Bio-Pharma LLC | 8 | $316 |
| Lilly USA, LLC | 10 | $181 |
| Vanda Pharmaceuticals Inc. | 9 | $152 |
| Axsome Therapeutics, Inc. | 8 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $124 |
| Alkermes, Inc. | 6 | $111 |
| Novo Nordisk Inc | 5 | $95 |
| PFIZER INC. | 5 | $85 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
Products named: QULIPTA, VRAYLAR, PROLATE, UBRELVY, MOUNJARO, CAPLYTA, VIVITROL, Wegovy.
Industry payments across NC — which companies pay providers there.
